⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLYS News
Mineralys Therapeutics, Inc. Common Stock
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MLYS
Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
globenewswire.com
MLYS
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MLYS
Form 8-K
sec.gov
MLYS
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
MLYS
Mineralys Therapeutics to Announce Second Quarter 2026 Financial Results and Host Conference Call on Tuesday, August 11, 2026
globenewswire.com
MLYS
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MLYS
Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
globenewswire.com
MLYS
Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
globenewswire.com
MLYS
Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)
globenewswire.com
MLYS